Skip to Content

Drug interactions between BuSpar and clindamycin / tretinoin topical

Results for the following 2 drugs:
BuSpar (buspirone)
clindamycin/tretinoin topical

Interactions between your drugs

There were no interactions found in our database between BuSpar and clindamycin / tretinoin topical - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

BuSpar

A total of 831 drugs are known to interact with BuSpar.

clindamycin / tretinoin topical

A total of 46 drugs are known to interact with clindamycin / tretinoin topical.

  • Clindamycin / tretinoin topical is a member of the drug class topical acne agents.
  • Clindamycin / tretinoin topical is used to treat Acne.

Drug and food interactions

Moderate

busPIRone food

Applies to: BuSpar (buspirone)

You should avoid the use of alcohol while being treated with busPIRone. Alcohol can increase the nervous system side effects of busPIRone such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. Patients receiving busPIRone should preferably avoid the consumption of large amounts of grapefruits and grapefruit juice. If this is not possible, the busPIRone dose should be taken at least 2 hours before or 8 hours after grapefruit or grapefruit juice. Large amounts of grapefruit and grapefruit juice may cause increased levels of busPIRone in your body. This can lead to increased adverse effects such as drowsiness. Talk to your doctor or pharmacist if you have any questions or concerns.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide